- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 58.3M sh |
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 58.06M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $32.96M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $28.56M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $40.8M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $37.16M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $521.53M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $529.71M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $714.16M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $753.95M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 50.19M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $351K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$31.64M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $485.46M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.64 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.64 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $9.47M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $28.72M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$32.09M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$38.18M |